APRE
Price
$1.62
Change
+$0.12 (+8.00%)
Updated
Apr 24, 04:55 PM (EDT)
Capitalization
8.82M
ATOS
Price
$0.73
Change
-$0.01 (-1.35%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
94.63M
24 days until earnings call
Ad is loading...

APRE vs ATOS

Header iconAPRE vs ATOS Comparison
Open Charts APRE vs ATOSBanner chart's image
Aprea Therapeutics
Price$1.62
Change+$0.12 (+8.00%)
Volume$400
Capitalization8.82M
Atossa Therapeutics
Price$0.73
Change-$0.01 (-1.35%)
Volume$4.96K
Capitalization94.63M
APRE vs ATOS Comparison Chart
Loading...
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APRE vs. ATOS commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APRE is a Hold and ATOS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (APRE: $1.52 vs. ATOS: $0.74)
Brand notoriety: APRE and ATOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APRE: 28% vs. ATOS: 212%
Market capitalization -- APRE: $8.82M vs. ATOS: $94.63M
APRE [@Biotechnology] is valued at $8.82M. ATOS’s [@Biotechnology] market capitalization is $94.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APRE’s FA Score shows that 2 FA rating(s) are green whileATOS’s FA Score has 1 green FA rating(s).

  • APRE’s FA Score: 2 green, 3 red.
  • ATOS’s FA Score: 1 green, 4 red.
According to our system of comparison, APRE is a better buy in the long-term than ATOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APRE’s TA Score shows that 4 TA indicator(s) are bullish while ATOS’s TA Score has 5 bullish TA indicator(s).

  • APRE’s TA Score: 4 bullish, 3 bearish.
  • ATOS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both APRE and ATOS are a good buy in the short-term.

Price Growth

APRE (@Biotechnology) experienced а -1.11% price change this week, while ATOS (@Biotechnology) price change was +21.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

APRE is expected to report earnings on Mar 25, 2025.

ATOS is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATOS($94.6M) has a higher market cap than APRE($8.82M). ATOS YTD gains are higher at: -21.830 vs. APRE (-53.799). APRE has higher annual earnings (EBITDA): -14.75M vs. ATOS (-29.46M). ATOS has more cash in the bank: 74.8M vs. APRE (26.2M). APRE (0) and ATOS (0) have identical debt. APRE (0) and ATOS (0) have equivalent revenues.
APREATOSAPRE / ATOS
Capitalization8.82M94.6M9%
EBITDA-14.75M-29.46M50%
Gain YTD-53.799-21.830246%
P/E RatioN/AN/A-
Revenue00-
Total Cash26.2M74.8M35%
Total Debt00-
FUNDAMENTALS RATINGS
ATOS: Fundamental Ratings
ATOS
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APREATOS
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AHEXY13.570.32
+2.45%
Adecco Group AG
NTDOY18.520.33
+1.81%
Nintendo Co., Ltd.
MRMD0.09N/A
+1.72%
MariMed Inc.
DIDIY4.16N/A
N/A
DiDi Global Inc.
GCEI0.07N/A
-0.14%
Global Clean Energy, Inc.

APRE and

Correlation & Price change

A.I.dvisor tells us that APRE and ATOS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APRE and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APRE
1D Price
Change %
APRE100%
-1.62%
ATOS - APRE
32%
Poorly correlated
+11.25%
KPRX - APRE
31%
Poorly correlated
+3.31%
NKTR - APRE
29%
Poorly correlated
+3.28%
CRVS - APRE
28%
Poorly correlated
+5.71%
ABOS - APRE
28%
Poorly correlated
+3.86%
More

ATOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with ABOS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATOS
1D Price
Change %
ATOS100%
+11.25%
ABOS - ATOS
53%
Loosely correlated
+3.86%
ERAS - ATOS
49%
Loosely correlated
+2.90%
ABCL - ATOS
49%
Loosely correlated
+0.79%
GBIO - ATOS
48%
Loosely correlated
+9.99%
NTLA - ATOS
45%
Loosely correlated
-2.65%
More